Feedback / Questions
HKT288 - MorphoSys, Novartis
berubicin (RTA 744) - Reata
http://www.globenewswire.com/news-release/2019/11/13/1946753/0/en/The-Benchmark-Company-LLC-Announces-Closing-of-Initial-Public-Offering-of-CNS-Pharmaceuticals-Inc.html
Nov 13, 2019
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next